557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial.
Saved in:
| Title: | 557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial. |
|---|---|
| Authors: | Coutzac, C.1 (AUTHOR), Bigot, F.2 (AUTHOR), Vansteene, D.3 (AUTHOR), Dos Santos, M.4 (AUTHOR), Ghiringhelli, F.5 (AUTHOR), You, B.6 (AUTHOR), Lambert, A.7 (AUTHOR), Gomez-Roca, C.A.8 (AUTHOR), Abdeddaim, C.9 (AUTHOR), Neuzillet, C.10 (AUTHOR), Jeannot, E.11 (AUTHOR), Guerini Rocco, E.12 (AUTHOR), Frige, G.13 (AUTHOR), Mazzarella, L.14 (AUTHOR), Dupain, C.15 (AUTHOR), Kamal, M.15 (AUTHOR), Legrand, F.16 (AUTHOR), Jimenez, M.16 (AUTHOR), Filleron, T.17 (AUTHOR), Le Tourneau, C.2 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS415-S415. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 173098636 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Coutzac%2C+C%2E%22">Coutzac, C.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bigot%2C+F%2E%22">Bigot, F.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Vansteene%2C+D%2E%22">Vansteene, D.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dos+Santos%2C+M%2E%22">Dos Santos, M.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ghiringhelli%2C+F%2E%22">Ghiringhelli, F.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22You%2C+B%2E%22">You, B.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lambert%2C+A%2E%22">Lambert, A.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gomez-Roca%2C+C%2EA%2E%22">Gomez-Roca, C.A.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Abdeddaim%2C+C%2E%22">Abdeddaim, C.</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Neuzillet%2C+C%2E%22">Neuzillet, C.</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jeannot%2C+E%2E%22">Jeannot, E.</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Guerini+Rocco%2C+E%2E%22">Guerini Rocco, E.</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frige%2C+G%2E%22">Frige, G.</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mazzarella%2C+L%2E%22">Mazzarella, L.</searchLink><relatesTo>14</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dupain%2C+C%2E%22">Dupain, C.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kamal%2C+M%2E%22">Kamal, M.</searchLink><relatesTo>15</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Legrand%2C+F%2E%22">Legrand, F.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Jimenez%2C+M%2E%22">Jimenez, M.</searchLink><relatesTo>16</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Filleron%2C+T%2E%22">Filleron, T.</searchLink><relatesTo>17</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Le+Tourneau%2C+C%2E%22">Le Tourneau, C.</searchLink><relatesTo>2</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2023 Supplement 2, Vol. 34, pS415-S415. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=173098636 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2023.09.1748 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S415 Titles: – TitleFull: 557MO Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic anal squamous cell carcinoma: Subgroup analysis of the PEVOsq basket trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Coutzac, C. – PersonEntity: Name: NameFull: Bigot, F. – PersonEntity: Name: NameFull: Vansteene, D. – PersonEntity: Name: NameFull: Dos Santos, M. – PersonEntity: Name: NameFull: Ghiringhelli, F. – PersonEntity: Name: NameFull: You, B. – PersonEntity: Name: NameFull: Lambert, A. – PersonEntity: Name: NameFull: Gomez-Roca, C.A. – PersonEntity: Name: NameFull: Abdeddaim, C. – PersonEntity: Name: NameFull: Neuzillet, C. – PersonEntity: Name: NameFull: Jeannot, E. – PersonEntity: Name: NameFull: Guerini Rocco, E. – PersonEntity: Name: NameFull: Frige, G. – PersonEntity: Name: NameFull: Mazzarella, L. – PersonEntity: Name: NameFull: Dupain, C. – PersonEntity: Name: NameFull: Kamal, M. – PersonEntity: Name: NameFull: Legrand, F. – PersonEntity: Name: NameFull: Jimenez, M. – PersonEntity: Name: NameFull: Filleron, T. – PersonEntity: Name: NameFull: Le Tourneau, C. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2023 Supplement 2 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 34 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
